Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A L Ajayi

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
International Journal of Cardiology. Cardiovascular Risk and Prevention|November 26, 2021
Pathophysiologically based antihypertensive pharmacotherapeutics rationality, efficacy and safety in Sub Saharan African Nations - A reviewA A L Ajayi, O E Ajayi
QJM : Monthly Journal of the Association of Physicians|April 12, 2005
Castration reduces platelet thromboxane A2 receptor density and aggregabilityA A L Ajayi, P V Halushka
Journal of Human Hypertension|April 26, 2003
Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugsA Q Adigun, D A Ishola, A O Akintomide, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
International Journal of Cardiology. Cardiovascular Risk and Prevention|November 26, 2021
Pathophysiologically based antihypertensive pharmacotherapeutics rationality, efficacy and safety in Sub Saharan African Nations - A reviewA A L Ajayi, O E Ajayi
QJM : Monthly Journal of the Association of Physicians|April 12, 2005
Castration reduces platelet thromboxane A2 receptor density and aggregabilityA A L Ajayi, P V Halushka
Journal of Human Hypertension|April 26, 2003
Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugsA Q Adigun, D A Ishola, A O Akintomide, et al.
Pageof 1